🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2003 | 50,19 | 51,52 | 50,19 | 51,44 | +2,49% | 2,64% | 6.044.026 |
| 13/02/2003 | 50,50 | 50,62 | 49,24 | 50,19 | -1,41% | 2,74% | 4.709.607 |
| 12/02/2003 | 51,62 | 51,64 | 50,71 | 50,91 | -1,22% | 1,81% | 4.664.753 |
| 11/02/2003 | 52,34 | 52,67 | 51,39 | 51,54 | -0,72% | 2,44% | 4.685.922 |
| 10/02/2003 | 51,13 | 52,08 | 50,67 | 51,91 | +1,57% | 2,76% | 5.964.797 |
| 07/02/2003 | 51,92 | 52,00 | 50,38 | 51,11 | -1,56% | 3,12% | 5.400.134 |
| 06/02/2003 | 51,67 | 52,59 | 51,38 | 51,92 | -0,46% | 2,33% | 5.942.160 |
| 05/02/2003 | 52,91 | 53,35 | 51,92 | 52,16 | -0,35% | 2,71% | 5.490.577 |
| 04/02/2003 | 52,58 | 52,67 | 52,00 | 52,34 | -1,81% | 1,27% | 5.982.403 |
| 03/02/2003 | 52,86 | 53,73 | 52,73 | 53,30 | +0,85% | 1,90% | 5.531.030 |
| 31/01/2003 | 51,88 | 53,16 | 51,69 | 52,85 | +1,61% | 2,83% | 5.904.118 |
| 30/01/2003 | 53,24 | 53,37 | 51,56 | 52,01 | -1,59% | 3,39% | 6.267.040 |
| 29/01/2003 | 51,67 | 53,29 | 51,53 | 52,85 | +1,82% | 3,42% | 6.969.305 |
| 28/01/2003 | 50,55 | 52,57 | 50,36 | 51,91 | +5,10% | 4,36% | 10.412.614 |
| 27/01/2003 | 50,86 | 51,14 | 49,14 | 49,39 | -3,34% | 3,92% | 8.840.404 |
| 24/01/2003 | 52,81 | 52,91 | 50,95 | 51,10 | -3,25% | 3,70% | 7.394.478 |
| 23/01/2003 | 53,08 | 53,52 | 52,34 | 52,81 | -0,49% | 2,23% | 6.183.410 |
| 22/01/2003 | 54,13 | 54,20 | 53,05 | 53,07 | -1,94% | 2,12% | 7.951.281 |
| 21/01/2003 | 55,11 | 55,19 | 53,96 | 54,12 | -2,78% | 2,23% | 8.075.888 |
| 17/01/2003 | 55,58 | 56,22 | 55,07 | 55,67 | -0,87% | 2,08% | 6.209.714 |
| 16/01/2003 | 56,57 | 57,00 | 55,82 | 56,15 | -0,74% | 2,09% | 5.537.527 |
| 15/01/2003 | 57,07 | 57,19 | 56,36 | 56,57 | -0,87% | 1,45% | 4.014.050 |
| 14/01/2003 | 56,82 | 57,16 | 56,43 | 57,07 | +0,02% | 1,28% | 3.959.134 |
| 13/01/2003 | 57,25 | 57,48 | 56,66 | 57,06 | -0,02% | 1,43% | 4.456.934 |
| 10/01/2003 | 57,04 | 57,23 | 56,40 | 57,07 | +0,05% | 1,46% | 5.104.179 |
| 09/01/2003 | 56,30 | 57,25 | 55,81 | 57,04 | +1,36% | 2,56% | 7.411.037 |
| 08/01/2003 | 56,40 | 56,82 | 56,11 | 56,28 | -0,22% | 1,27% | 4.983.030 |
| 07/01/2003 | 56,87 | 57,30 | 56,34 | 56,40 | -1,29% | 1,69% | 6.692.947 |
| 06/01/2003 | 56,06 | 57,22 | 56,06 | 57,14 | +1,51% | 2,08% | 4.852.659 |
| 03/01/2003 | 55,82 | 56,53 | 55,73 | 56,29 | +1,27% | 1,42% | 5.419.837 |